← FDA DRUG APPROVALS

FDA ANDA · ANDA079044

NICOTINE

nicotine polacrilex

Sponsor: P AND L

APPLICATION
ANDA079044
TYPE
ANDA
ORIGINAL APPROVAL
2009-07-08
LATEST ACTION
2017-04-12
ROUTE
BUCCAL, ORAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Over-the-counter

Products

NICOTINE POLACRILEXOver-the-counter
NICOTINE POLACRILEX EQ 2MG BASE · GUM, CHEWING · BUCCAL

Approval history

2017-04-12Labeling · Supplement 15 · standardAP
2015-04-30Labeling · Supplement 10 · standardAP
2013-01-28Labeling · Supplement 8 · standardAP
2009-07-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →